Enanta Pharmaceuticals (ENTA) Institutional Ownership

$13.80 -0.35 (-2.47%)

Closing price 08/27/2026 04:00 PM Eastern

Extended Trading

$13.78 -0.02 (-0.11%)

As of 08/27/2026 07:30 PM Eastern

Compare

Current Institutional Ownership Percentage: 94.99%
Number of Institutional Buyers (last 12 months): 67
Total Institutional Inflows (last 12 months): $246.87M

Number of Institutional Sellers (last 12 months): 23
Total Institutional Outflows (last 12 months): $14.81M

Get ENTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enanta Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ENTA Institutional Buying and Selling by Quarter

Enanta Pharmaceuticals Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/24/2026	California State Teachers Retirement System	5,570	$81K	0.0%	+277.4%	0.019%
8/20/2026	Headlands Technologies LLC	17,686	$258K	0.0%	-21.8%	0.061%
8/19/2026	Wellington Management Group LLP	81,633	$1.19M	0.0%	+8.9%	0.280%
8/17/2026	Bank of America Corp DE	21,536	$314K	0.0%	N/A	0.074%
8/15/2026	Jupiter Topco LLC	3,654,920	$53.25M	0.0%	N/A	12.551%
8/14/2026	ADAR1 Capital Management LLC	1,344,510	$19.60M	0.9%	N/A	4.624%
8/14/2026	Legal & General Group Plc	2,810	$41K	0.0%	N/A	0.010%
8/14/2026	Spruce Street Capital LP	1,088,731	$15.87B	3.1%	N/A	3.744%
8/13/2026	Connor Clark & Lunn Investment Management Ltd.	153,008	$2.23M	0.0%	N/A	0.526%
8/12/2026	Ieq Capital LLC	38,508	$561K	0.0%	N/A	0.132%
Get the Latest News and Ratings for ENTA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
8/7/2026	BlackRock Inc.	3,244,448	$47.30M	0.0%	N/A	11.157%
8/7/2026	Deutsche Bank AG	27,951	$408K	0.0%	N/A	0.096%
8/6/2026	Bank of New York Mellon Corp	76,756	$1.12M	0.0%	N/A	0.264%
8/6/2026	GSA Capital Partners LLP	32,486	$474K	0.0%	N/A	0.112%
8/6/2026	Clearstead Trust LLC	5,064	$74K	0.0%	N/A	0.017%
5/19/2026	Bank of America Corp DE	26,593	$336K	0.0%	-59.7%	0.091%
5/19/2026	Janus Henderson Group PLC	3,784,055	$47.72M	0.0%	+1.5%	13.013%
5/18/2026	ADAR1 Capital Management LLC	51,357	$649K	0.0%	+24.2%	0.177%
5/16/2026	Quantinno Capital Management LP	35,122	$444K	0.0%	+4.9%	0.121%
5/15/2026	Spruce Street Capital LP	932,598	$11.78M	2.8%	+139.3%	3.214%
5/14/2026	Renaissance Technologies LLC	665,258	$8.40M	0.0%	+3.6%	2.292%
5/14/2026	Sei Investments Co.	109,077	$1.38M	0.0%	+10.4%	0.376%
5/14/2026	State of Wyoming	13,473	$170K	0.0%	-59.0%	0.046%
5/7/2026	Dimensional Fund Advisors LP	203,252	$2.57M	0.0%	-4.0%	0.700%
5/5/2026	Bank of New York Mellon Corp	70,783	$894K	0.0%	-2.5%	0.244%
5/5/2026	Hillsdale Investment Management Inc.	435,510	$5.50M	0.1%	+3.1%	1.501%
2/26/2026	Seven Fleet Capital Management LP	2,270	$36K	0.0%	N/A	0.008%
2/23/2026	Virtu Financial LLC	13,967	$220K	0.0%	N/A	0.048%
2/19/2026	Invesco Ltd.	253,811	$4.00M	0.0%	+325.2%	0.875%
2/18/2026	Krensavage Asset Management LLC	2,766,390	$43.63M	15.4%	+30.8%	9.533%
2/18/2026	Wellington Management Group LLP	63,219	$997K	0.0%	N/A	0.218%
2/18/2026	Opaleye Management Inc.	75,000	$1.18M	0.2%	N/A	0.258%
2/18/2026	Millennium Management LLC	670,428	$10.57M	0.0%	-40.2%	2.310%
2/18/2026	Man Group plc	43,847	$691K	0.0%	+9.2%	0.151%
2/18/2026	Janus Henderson Group PLC	3,729,659	$58.76M	0.0%	+91.6%	12.852%
2/17/2026	ADAR1 Capital Management LLC	41,357	$652K	0.0%	N/A	0.143%
2/17/2026	PDT Partners LLC	69,197	$1.09M	0.1%	-19.6%	0.238%
2/17/2026	AQR Capital Management LLC	234,835	$3.70M	0.0%	+3.5%	0.809%
2/17/2026	Jain Global LLC	12,543	$198K	0.0%	N/A	0.043%
2/17/2026	Jump Financial LLC	13,900	$219K	0.0%	N/A	0.048%
Nvidia's CEO says this small device is critical for AI growth (Ad) A tiny glass device smaller than a fingertip could redefine AI hardware. Nvidia CEO Jensen Huang calls it essential for AI to scale, while Sequoia Capital labels it a holy grail. Stocks tied to this technology have already surged 133 percent, 217 percent, and 320 percent in recent months, according to Brownstone Research analyst Jason Bodner, who identified Nvidia at 4.50. Click now to discover Bodner's top AI stock pick before others catch on
2/17/2026	Farallon Capital Management LLC	2,772,262	$43.72M	0.2%	+30.6%	9.553%
2/17/2026	Price T Rowe Associates Inc. MD	14,410	$228K	0.0%	+42.0%	0.050%
2/17/2026	Diadema Partners LP	65,138	$1.03M	0.2%	N/A	0.224%
2/17/2026	Russell Investments Group Ltd.	11,483	$182K	0.0%	-30.2%	0.040%
2/17/2026	State of Wisconsin Investment Board	18,608	$293K	0.0%	N/A	0.064%
2/17/2026	Persistent Asset Partners Ltd	17,466	$275K	0.1%	N/A	0.060%
2/16/2026	Squarepoint Ops LLC	65,966	$1.04M	0.0%	N/A	0.227%
2/16/2026	Spruce Street Capital LP	389,687	$6.15M	2.0%	N/A	1.343%
2/16/2026	Panagora Asset Management Inc.	66,990	$1.06M	0.0%	N/A	0.231%
2/16/2026	Barclays PLC	54,989	$867K	0.0%	+32.1%	0.189%
2/13/2026	Marshall Wace LLP	385,276	$6.08M	0.0%	+39.9%	1.328%
2/13/2026	Hudson Bay Capital Management LP	30,000	$473K	0.0%	N/A	0.103%
2/13/2026	Headlands Technologies LLC	22,596	$356K	0.0%	N/A	0.078%
2/13/2026	Charles Schwab Investment Management Inc.	218,636	$3.45M	0.0%	+31.3%	0.753%
2/13/2026	State Street Corp	523,715	$8.26M	0.0%	+11.0%	1.805%
2/13/2026	Ieq Capital LLC	36,385	$574K	0.0%	-3.5%	0.125%
2/13/2026	Wells Fargo & Company MN	30,716	$484K	0.0%	+96.9%	0.106%
2/12/2026	MetLife Investment Management LLC	14,408	$227K	0.0%	+119.7%	0.050%
2/12/2026	Renaissance Technologies LLC	642,200	$10.13M	0.0%	+33.9%	2.213%
2/12/2026	Dimensional Fund Advisors LP	211,614	$3.34M	0.0%	-21.6%	0.729%
2/12/2026	Informed Momentum Co LLC	40,952	$646K	0.1%	N/A	0.141%
2/12/2026	New York State Common Retirement Fund	6,071	$96K	0.0%	-21.9%	0.021%
2/12/2026	Campbell & CO Investment Adviser LLC	54,149	$854K	0.0%	+187.2%	0.187%
2/12/2026	Bank of Montreal Can	37,484	$591K	0.0%	+10.7%	0.129%
2/12/2026	Nuveen LLC	86,056	$1.36M	0.0%	-47.8%	0.297%
2/11/2026	Meeder Asset Management Inc.	2,025	$32K	0.0%	N/A	0.007%
2/11/2026	Deutsche Bank AG	24,107	$380K	0.0%	+4.6%	0.083%
2/11/2026	Fox Run Management L.L.C.	10,182	$161K	0.0%	N/A	0.035%
2/11/2026	Franklin Resources Inc.	32,720	$516K	0.0%	N/A	0.113%
2/11/2026	State of Wyoming	32,887	$519K	0.1%	N/A	0.113%
2/10/2026	Goldman Sachs Group Inc.	218,816	$3.45M	0.0%	+31.5%	0.754%
2/10/2026	Hillsdale Investment Management Inc.	422,300	$6.66M	0.2%	N/A	1.455%
2/9/2026	Kingsview Wealth Management LLC	10,653	$168K	0.0%	N/A	0.037%
2/9/2026	Geode Capital Management LLC	645,791	$10.19M	0.0%	+30.9%	2.225%
2/2/2026	Strs Ohio	3,200	$50K	0.0%	N/A	0.011%
1/29/2026	China Universal Asset Management Co. Ltd.	4,703	$74K	0.0%	-46.2%	0.016%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	3,584	$57K	0.0%	+333.9%	0.012%
1/9/2026	Assenagon Asset Management S.A.	45,877	$723K	0.0%	-15.4%	0.159%
1/1/2026	JPMorgan Chase & Co.	123,817	$1.48M	0.0%	-5.1%	0.429%
1/1/2026	Tudor Investment Corp ET AL	10,443	$125K	0.0%	N/A	0.036%
12/9/2025	Tudor Investment Corp ET AL	10,443	$125K	0.0%	N/A	0.036%
11/17/2025	Harvest Investment Services LLC	12,193	$146K	0.0%	N/A	0.057%
11/17/2025	Jacobs Levy Equity Management Inc.	169,048	$2.02M	0.0%	-12.0%	0.791%
11/17/2025	PharVision Advisers LLC	35,846	$429K	0.2%	N/A	0.168%
11/17/2025	Quarry LP	6,752	$81K	0.0%	N/A	0.032%
11/17/2025	Qube Research & Technologies Ltd	11,920	$143K	0.0%	-85.8%	0.056%
11/17/2025	Public Employees Retirement System of Ohio	14,412	$173K	0.0%	+8.3%	0.067%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	9,706	$116K	0.0%	-15.4%	0.045%
11/17/2025	Commodore Capital LP	800,000	$9.58M	0.5%	N/A	3.742%
11/17/2025	Bank of America Corp DE	29,952	$359K	0.0%	-47.5%	0.140%
It’s not about Greenland (Ad) The petrodollar arrangement that anchored the US dollar for 50 years quietly expired in June 2024. Since then, China has cut its Treasury holdings by 45% from their peak, and BRICS nations offloaded $47 billion of American debt in a single month. The Trump administration has responded with a $12 billion critical minerals stockpile called Project Vault, equity stakes in miners like MP Materials and Lithium Americas, and a push to secure resources from Greenland to Ukraine. Porter Stansberry lays out the full story in a new documentary, including five companies positioned at the chokepoints of what he calls Trump's New Dollar. Watch the full documentary before December's economic summit in Miami
11/17/2025	Algert Global LLC	11,106	$133K	0.0%	N/A	0.052%
11/17/2025	Ameriprise Financial Inc.	18,007	$216K	0.0%	+8.3%	0.084%
11/14/2025	Man Group plc	40,156	$481K	0.0%	N/A	0.188%
11/14/2025	Occudo Quantitative Strategies LP	15,549	$186K	0.0%	N/A	0.073%
11/14/2025	Two Sigma Investments LP	60,722	$727K	0.0%	-22.6%	0.284%
11/13/2025	BNP Paribas Financial Markets	19,820	$237K	0.0%	-49.5%	0.093%
11/13/2025	Russell Investments Group Ltd.	16,443	$197K	0.0%	+13.4%	0.077%
11/12/2025	Dimensional Fund Advisors LP	270,068	$3.24M	0.0%	-2.7%	1.263%
11/10/2025	Portland Global Advisors LLC	24,275	$291K	0.0%	-26.8%	0.114%
11/10/2025	China Universal Asset Management Co. Ltd.	8,747	$105K	0.0%	+103.8%	0.041%

ENTA Institutional Ownership - Frequently Asked Questions

During the previous two years, 121 institutional investors and hedge funds held shares of Enanta Pharmaceuticals. The most heavily invested institutionals were Spruce Street Capital LP ($15.87B), Jupiter Topco LLC ($53.25M), Janus Henderson Group PLC ($47.72M), BlackRock Inc. ($47.30M), Farallon Capital Management LLC ($43.72M), Krensavage Asset Management LLC ($43.63M), and Vanguard Group Inc. ($23.21M).Learn more on Enanta Pharmaceuticals' institutional investors.

94.99% of Enanta Pharmaceuticals' stock is owned by institutional investors. Learn more on ENTA's institutional investor holdings.

Of the 105 institutional investors that purchased Enanta Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Jupiter Topco LLC ($3.65M), BlackRock Inc. ($3.24M), Spruce Street Capital LP ($2.02M), Janus Henderson Group PLC ($1.84M), ADAR1 Capital Management LLC ($1.40M), RA Capital Management L.P. ($1.04M), and Krensavage Asset Management LLC ($898.68K).

Institutional investors have bought a total of 16,755,341 shares in the last 24 months. This purchase volume represents approximately $246.87M in transactions.

Of the 23 institutional investors that sold Enanta Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($451.46K), Nuveen LLC ($78.70K), Dimensional Fund Advisors LP ($74.39K), Qube Research & Technologies Ltd ($71.99K), Bank of America Corp DE ($66.44K), Assenagon Asset Management S.A. ($60.50K), and Thrivent Financial for Lutherans ($51.79K).

Institutional investors have sold a total of 1,033,607 shares in the last 24 months. This volume of shares sold represents approximately $14.81M in transactions.

Related Companies

Institutional ownership data for NASDAQ:ENTA is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/24/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Enanta Pharmaceuticals (ENTA) Institutional Ownership

ENTA Institutional Buying and Selling by Quarter

Enanta Pharmaceuticals Major Shareholders & Ownership History

ENTA Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Enanta Pharmaceuticals (ENTA) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Enanta Pharmaceuticals (NASDAQ:ENTA)

ENTA Institutional Buying and Selling by Quarter

Enanta Pharmaceuticals Major Shareholders & Ownership History

ENTA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ENTA shares?

What percentage of Enanta Pharmaceuticals' stock is owned by institutional investors?

Which institutional investors have been buying Enanta Pharmaceuticals' stock?

How much institutional buying is happening at Enanta Pharmaceuticals?

Which of Enanta Pharmaceuticals' major shareholders have been selling company stock?

How much institutional selling is happening at Enanta Pharmaceuticals?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools